The Recombinant DNA Technologies

  • Irina Pollard


Recent developments in genetic engineering have brought an unprecedented increase in our power over living things. Gene mapping together with recombinant excising and splicing techniques hold great promise for producing new kinds of plants, animals, drugs and for treating human genetic diseases. Transgenic plants and animals are genetically novel creatures because they carry integrated foreign genes, which are correctly expressed and inherited by subsequent generations.


Cystic Fibrosis Neonatal Screening Carrier Screening Future Child Polygenic Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected Bibliography

  1. Appleyard, B. Brave New World: Staying Human in the Genetic Future. London, Harper Collins 1999.Google Scholar
  2. British Medical Association. Human Genetics: Choice and Responsibility. Oxford, Oxford University Press 1998.Google Scholar
  3. Cohen, C. Wrestling with the future: should we test children for adult-onset genetic conditions? Kennedy Institute of Ethics Journal 8:1998;111–130.PubMedCrossRefGoogle Scholar
  4. Dodson, M & Williamson, R. Indigenous peoples and the morality of the Human Genome Diversity Project. Journal of Medical Ethics 25:1999;204–208.PubMedCrossRefGoogle Scholar
  5. Dronamraju, K. Biological and Social Issues in Biotechnology Sharing. Aldershot, Ashgate 1998.Google Scholar
  6. Fujiki, N. & Macer, D. (Ed). Bioethics in Asia: Proceedings of the UNESCO Asian Bioethics Conference and the WHO-assisted satellite symposium on medical genetics services. Tsukuba, Eubios Ethics Institute 1998.Google Scholar
  7. Jolles, P. (Ed). New Approaches to Drug Development. Basel, Birkhauser Verlag 2000.Google Scholar
  8. Jung, U., Urner, U., Grade, K. & Coutelle, C. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population. Human Genetics 94:1995;19–24.CrossRefGoogle Scholar
  9. Junker-Kenny, M. (Ed). Designing Life? Genetics, Procreation and Ethics. Aldershot, Ashgate 1999.Google Scholar
  10. Kaprio, J. Genetic epidemiology. British Medical Journal 320:2000;1257–1261.PubMedCrossRefGoogle Scholar
  11. Lawson, C. Patenting genetic materials: Old rules may be restricting the exploitation of a new technology. Journal of Law and Medicine 6:1999;373–388.Google Scholar
  12. Livesey, F. & Hunt, S. (Ed). Functional Genomics. Oxford, Oxford University Press 2000.Google Scholar
  13. Macer, D. (Ed). Ethical Challenges as We Approach the End of the Human Genome Project. Tsukuba, Eubios Ethics Institute 2000.Google Scholar
  14. Miller, P. Genetic discrimination in the workplace. Journal of Law, Medicine & Ethics 26:1998;189–197.CrossRefGoogle Scholar
  15. Rios, J., Orellana, O., Aspillaga, M., Avendano, I., Largo, I & Riveros, N. CFTR mutations in Chilean cystic fibrosis patients. Human Genetics, 94:1995;291–294.Google Scholar
  16. Science 22 December 2000 volume 290 ( is devoted to articles about the new breakthroughs in Genomics.
  17. Weatherall, D. Single gene disorders or complex traits: Lessons from the thalassaemias and other monogenic diseases. British Medical Journal 321:2000; 1117–1120.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Irina Pollard
    • 1
  1. 1.Biological SciencesMacquarie UniversitySydneyAustralia

Personalised recommendations